Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

N'-(5-chloro-2-hydroxy-3-methylbenzylidene)-2,4-dihydroxybenzhydrazide

EU orphan designation number: EU/3/08/568   
Active ingredient: N'-(5-chloro-2-hydroxy-3-methylbenzylidene)-2,4-dihydroxybenzhydrazide
Indication: Treatment of partial deep dermal and full thickness burn wounds
Sponsor: Creative Antibiotics Sweden AB
Box 7953, Tvistevägen 48, SE-907 19 Urneå, Sverige

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/09/2008 Centralised Orphan - Designation EMEA/OD/029/08 (2008)5451 of 22/09/2008
01/03/2011 Other procedure EMEA/OD/029/08